Bristol-Myers Squibb

Bristol-Myers' Abilify coupons prevail in health-plan lawsuit
Fierce Pharma
Tue, 06/4/13 - 01:00 pm
drug coupons
Bristol-Myers Squibb
Abilify
Analyst: Cancer Drugs Push Investors Into Pharma
Barron's
Tue, 06/4/13 - 10:00 am
cancer
ASCO
Merck
Bristol-Myers Squibb
Drugs Go From Hit to Dud in Two Years in Hepatitis Race
Bloomberg
Mon, 06/3/13 - 10:27 am
hepatitis C
Merck
Gilead
Vertex Pharmaceuticals
JNJ
Medivir
Bristol-Myers Squibb
Bristol And Merck's Cancer Drugs Won ASCO. Five Slides Explain Why.
TheStreet.com
Mon, 06/3/13 - 10:20 am
nivolumab
Merck
melanoma
lambrolizumab
Bristol-Myers Squibb
ASCO
New Approvals Spark a Melanoma Drug Battle
Motley Fool
Sat, 06/1/13 - 12:48 pm
melanoma
GSK
Tafinlar
Mekinist
Roche
Bristol-Myers Squibb
Bristol drug shrinks melanoma in 31 pct of trial patients
Reuters
Sat, 06/1/13 - 12:24 pm
nivolumab
Bristol-Myers Squibb
melanoma
Cancer Immunotherapy the Top Focus at ASCO
CNBC
Fri, 05/31/13 - 12:31 pm
ASCO
immunotherapy
cancer
Bristol-Myers Squibb
Roche
and Merck
Doctor’s Doubts Imperil Lucrative Diabetes Drugs
NY Times, NY
Thu, 05/30/13 - 04:51 pm
physicians
diabetes
Bristol-Myers Squibb
Byetta
Merck
AstraZeneca
Januvia
Novo Nordisk
Eli Lilly
Takeda
Boehringer Ingelheim
ASCO presentations portend future shock of immunotherapy drug prices
Fierce Biotech
Thu, 05/30/13 - 11:37 am
ASCO
drug pricing
immunotherapy
Merck
Bristol-Myers Squibb
Diabetes Drug From Bristol and Astra Wins U.K. Panel’s Backing
Bloomberg
Thu, 05/30/13 - 08:56 am
diabetes
Bristol-Myers Squibb
AstraZeneca
UK
Forixga
3 Stocks to Watch Ahead of ASCO
Motley Fool
Tue, 05/28/13 - 06:28 pm
cancer
ASCO
nivolumab
Bristol-Myers Squibb
idelalisad
Gilead
PEGPH20
Halozyme
pancreatic cancer
5 Pharmaceutical Stocks to Buy Now
InvestorPlace
Sat, 05/25/13 - 12:38 pm
Alimera
JNJ
Bristol-Myers Squibb
Watson Pharmaceuticals
Repros Therapeutics
Bristol-Myers Squibb (BMY) Shares Cross 3% Yield Mark
Forbes
Sat, 05/25/13 - 12:15 pm
Bristol-Myers Squibb
J&J: We're Creaming Medivation, Boehringer, Bristol And Pfizer
Forbes
Thu, 05/23/13 - 10:44 am
JNJ
Medivation
Boehringer Ingelheim
Pfizer
Bristol-Myers Squibb
Xarelto
Zytiga
Roche, Reloaded
Investopedia
Wed, 05/22/13 - 09:22 am
Roche
Gilead
Merck
Bristol-Myers Squibb
JNJ
Bristol Myers Squibb And The New Wave Of Cancer Drugs
Seeking Alpha
Mon, 05/20/13 - 05:26 pm
Bristol-Myers Squibb
Merck
nivolumab
lambrolizumab
Roche
PD-L1
melanoma
cancer
lung cancer
Tackling Cancer: Leukemia's Biggest Current and Upcoming Players
Motley Fool
Mon, 05/20/13 - 11:40 am
leukemia
Sprycel
Bristol-Myers Squibb
Gleevec
Novartis
Iclusig
Ariad Pharmaceuticals
Bosulif
Pfizer
Erwinaze
Jazz Pharmaceuticals
Idelalisib
Gilead
ibrutinib
Pharmacyclics
Shire may return cash to thwart takeover, Daily Mail reports
Yahoo/Fly on the Wall
Mon, 05/20/13 - 09:50 am
Shire
M&A
Bristol-Myers Squibb
4 Pharmaceutical Stocks to Buy Now
InvestorPlace
Sat, 05/18/13 - 12:24 pm
JNJ
Bristol-Myers Squibb
Watson Pharmaceuticals
Repros Therapeutics
Bristol-Myers Squibb Company (BMY): Today's Featured Drugs Winner
The Street
Sat, 05/18/13 - 12:08 pm
Bristol-Myers Squibb

Pages